Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 137

1.

Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins.

Ferdinand KC, Balavoine F, Besse B, Black HR, Desbrandes S, Dittrich HC, Nesbitt SD.

Circulation. 2019 Jul 9;140(2):138-146. doi: 10.1161/CIRCULATIONAHA.119.040070. Epub 2019 Apr 24.

PMID:
31014072
2.

Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.

Bangalore S, Davis BR, Cushman WC, Pressel SL, Muntner PM, Calhoun DA, Kostis JB, Whelton PK, Probstfield JL, Rahman M, Black HR; ALLHAT Collaborative Research Group.

Am J Med. 2017 Apr;130(4):439-448.e9. doi: 10.1016/j.amjmed.2016.10.002. Epub 2016 Oct 27.

3.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.

Black HR, Sica D, Ferdinand K, White WB; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology.

Circulation. 2015 Dec 1;132(22):e298-302. doi: 10.1161/CIR.0000000000000242. Epub 2015 Nov 2. Review. No abstract available.

PMID:
26621647
4.

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.

Black HR, Sica D, Ferdinand K, White WB.

J Am Coll Cardiol. 2015 Dec 1;66(21):2393-2397. doi: 10.1016/j.jacc.2015.09.038. Epub 2015 Nov 2. No abstract available.

5.

Clinical Use of Pulse Wave Analysis: Proceedings From a Symposium Sponsored by North American Artery.

Townsend RR, Black HR, Chirinos JA, Feig PU, Ferdinand KC, Germain M, Rosendorff C, Steigerwalt SP, Stepanek JA.

J Clin Hypertens (Greenwich). 2015 Jul;17(7):503-13. doi: 10.1111/jch.12574. Epub 2015 May 23.

6.

Lack of blood pressure difference by race in professional American football players.

Tucker AM, Lincoln AE, Vogel RA, Black HR, Dunn RE, Wilson PW, Pellman EJ.

J Am Soc Hypertens. 2015 May;9(5):370-4. doi: 10.1016/j.jash.2015.02.019. Epub 2015 Mar 11.

PMID:
25979411
7.

Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O'Connor CM, O'Gara PT, Ogedegbe O, Oparil S, White WB; American Heart Association, American College of Cardiology, and American Society of Hypertension.

J Am Soc Hypertens. 2015 Jun;9(6):453-98. doi: 10.1016/j.jash.2015.03.002. Epub 2015 Mar 31. Review. No abstract available.

PMID:
25840695
8.

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O'Connor CM, O'Gara PT, Ogedegbe O, Oparil S, White WB; American Heart Association; American College of Cardiology; American Society of Hypertension.

J Am Coll Cardiol. 2015 May 12;65(18):1998-2038. doi: 10.1016/j.jacc.2015.02.038. Epub 2015 Mar 31. No abstract available. Erratum in: J Am Coll Cardiol. 2016 Oct 18;68(16):1822.

9.

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O'Connor CM, O'Gara PT, Ogedegbe G, Oparil S, White WB; American Heart Association, American College of Cardiology, and American Society of Hypertension.

Circulation. 2015 May 12;131(19):e435-70. doi: 10.1161/CIR.0000000000000207. Epub 2015 Mar 31. No abstract available. Erratum in: Circulation. 2016 Sep 20;134(12):e260.

PMID:
25829340
10.

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O'Connor CM, O'Gara PT, Ogedegbe G, Oparil S, White WB; American Heart Association, American College of Cardiology, and American Society of Hypertension.

Hypertension. 2015 Jun;65(6):1372-407. doi: 10.1161/HYP.0000000000000018. Epub 2015 Mar 31. Review. No abstract available. Erratum in: Hypertension. 2016 Oct;68(4):e61.

PMID:
25828847
11.

Treatment: special conditions: resistant hypertension.

Black HR.

J Am Soc Hypertens. 2015 Jan;9(1):71-4; quiz 75. doi: 10.1016/j.jash.2014.12.006. Epub 2014 Dec 16. No abstract available.

PMID:
25641108
12.

Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, Black HR, Kostis JB, Probstfield JL, Whelton PK, Rahman M; ALLHAT Collaborative Research Group.

Hypertension. 2014 Nov;64(5):1012-21. doi: 10.1161/HYPERTENSIONAHA.114.03850. Epub 2014 Aug 4.

PMID:
25259745
13.

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease.

Stroke. 2014 Jul;45(7):2160-236. doi: 10.1161/STR.0000000000000024. Epub 2014 May 1. Erratum in: Stroke. 2015 Feb;46(2):e54.

PMID:
24788967
14.

Use of ambulatory blood pressure monitoring to guide hypertensive therapy.

Singh A, Gianos E, Schwartzbard A, Black H, Weintraub H.

Curr Treat Options Cardiovasc Med. 2013 Dec;15(6):746-60. doi: 10.1007/s11936-013-0255-4.

PMID:
23839274
15.

Association of Clinical Researchers and Educators a statement on relationships between physicians and industry.

Weber MA, Black HR, Fonseca R, Garber J, Gonzalez-Campoy JM, Kimmelstiel C, Markowitz AB, Nakayama D, Stell LK, Stossel TP.

Endocr Pract. 2012 Nov-Dec;18(6):1029-37. doi: 10.4158/EP12163.CO.

PMID:
22982801
16.

Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES).

Giles TD, Black HR, Messerli F, White WB.

J Am Soc Hypertens. 2012 Sep-Oct;6(5):364-6. doi: 10.1016/j.jash.2012.07.002. Epub 2012 Aug 28. No abstract available.

PMID:
22951099
18.

Kidney dysfunction, cardiorespiratory fitness, and the risk of death in women.

Gulati M, Black HR, Arnsdorf MF, Shaw LJ, Bakris GL.

J Womens Health (Larchmt). 2012 Sep;21(9):917-24. doi: 10.1089/jwh.2011.3406. Epub 2012 Apr 5.

PMID:
22480201
19.

Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study.

Neutel JM, Mancia G, Black HR, Dahlöf B, Defeo H, Ley L, Vinisko R; TEAMSTA Severe HTN Study Investigators.

J Clin Hypertens (Greenwich). 2012 Apr;14(4):206-15. doi: 10.1111/j.1751-7176.2012.00595.x. Epub 2012 Feb 23.

20.

Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study.

Barzilay JI, Davis BR, Pressel SL, Cutler JA, Einhorn PT, Black HR, Cushman WC, Ford CE, Margolis KL, Moloo J, Oparil S, Piller LB, Simmons DL, Sweeney ME, Whelton PK, Wong ND, Wright JT Jr; ALLHAT Collaborative Research Group.

Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):153-62. doi: 10.1161/CIRCOUTCOMES.111.962522. Epub 2012 Mar 6.

Supplemental Content

Loading ...
Support Center